BeStock  
Stocks › VRDN

Viridian Therapeutics VRDN

US equityMarket cap rank #2720
$19.00 −$0.40 (-2.06%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $19.00 0.00%
Open$19.41
Prev close$19.40
Day range$18.83 – $19.59
Volume2.65M
Market cap$2.15B
P/E (TTM)–
Dividend yield–

Where the revenue comes from

Quarter 2026/Q1

By business line

  • Collaboration revenue - related parties$135,000.00 95.7%
  • Discovering, developing and commercializing potential best-in-class medicines for serious and rare$6,000.00 4.3%

Cash flow

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Other Non-Cash Items $2.34M $2.51M $4.20M $89,000.00 $92,000.00
Net cash flow from investing -$231.16M $77.26M -$339.42M $126.08M $75.72M
Net Cash Flow from Continuing Investing Activities -$231.16M $77.26M -$339.42M $126.08M $75.72M
Net PPE Purchase and Sale -$1.31M -$23,000.00 -$240,000.00 -$127,000.00 -$42,000.00
Net Investment Purchase and Sale -$229.85M $77.28M -$339.18M $126.20M $75.76M
Financing Cash Flow $325.12M $6.36M $405.91M $10.86M $764,000.00
Net Cash Flow from Continuing Financing Activities $325.12M $6.36M $405.91M $10.86M $764,000.00
Net Common Stock Issuance $143.75M $0.00 $337.29M $9.96M $1,000.00
Proceeds from Stock Option Exercised $1.85M $6.36M $8.45M $1.11M $763,000.00
Ending Cash Balance $164.99M $176.35M $212.38M $169.65M $117.32M
Net Change in Cash -$11.36M -$36.04M $42.74M $52.32M $1.11M
Beginning Cash Balance $176.35M $212.38M $169.65M $117.32M $116.22M
Free Cash Flow -$106.63M -$119.68M -$23.99M -$84.74M -$75.42M
-Change in Payables and Accrued Expense $909,000.00 -$19.06M $19.94M $6.16M $10.82M
-Change in Prepaid Assets -$2.40M -$2.33M -$8.59M $3.37M $5.19M
Operating Cash Flow -$105.32M -$119.65M -$23.75M -$84.61M -$75.37M
Net cash flow from continuing operations -$105.32M -$119.65M -$23.75M -$84.61M -$75.37M
Net Income from Continuing Operations -$127.12M -$104.90M -$120.36M -$34.60M -$100.74M
Gain/Loss from Continuing Operations $5.64M -$7.53M – – –
Depreciation & Depletion & Amortization $117,000.00 $121,000.00 $120,000.00 $110,000.00 $113,000.00
Change in Working Capital -$1.84M -$21.39M $81.35M -$60.33M $15.87M
Net Other Financing Charges – – $31.30M -$209,000.00 $0.00
Net Preferred Stock Issuance – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on VRDN.

Leave a comment

Scroll to Top